Back to all news
AI Model Predicts Colorectal Cancer Survival by Integrating Clinical and Molecular Data
A research team developed a machine learning model that predicts colorectal cancer survival using combined clinical and molecular features, achieving high accuracy.
Key Details
- 1Study analyzed data from over 500 colorectal cancer patients using clinical (age, stage, chemotherapy) and molecular (gene/microRNA) features.
- 2Adaptive boosting ML model achieved 89.58% accuracy for survival prediction.
- 3Key predictive features included pathological stage, E2F8 gene expression, WDR77, and hsa-miR-495-3p microRNA.
- 4Combining clinical and biological data outperformed models using either data type alone.
- 5Study used publicly available data from the TCGA database; patient lifestyle factors were not included but seen as important for future work.
Why It Matters
The integration of clinical and molecular data using machine learning could enhance personalized risk stratification and treatment planning in colorectal cancer, an area of substantial clinical need. Such research advances the potential for AI-driven precision medicine in oncology and radiology.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.